Hemopoietin receptor protein, NR12

Details Hemopoietin receptor protein, NR12 Hemopoietin receptor protein, NR12

2011-02-22

2011-02-22

Allen, Marianne P (Department: 1647)

Chemistry: natural resins or derivatives; peptides or proteins;

Proteins, i.e., more than 100 amino acid residues

C530S395000, C530S397000

Reexamination Certificate

active

07893201

ABSTRACT:
A novel hemopoietin receptor gene (NR12) was successfully isolated by extracting motifs conserved among the amino acid sequences of known hemopoietin receptors and by using the predicted sequence. The NR12 gene encodes two forms of proteins, a transmembrane type and a soluble type. The expression of the NR12 gene was detected in tissues containing hematopoietic cells. NR12 is a novel hemopoietin receptor molecule involved in the regulation of immune system and hematopoiesis in vivo. Thus, NR12 is useful in the search for novel hematopoietic factors that functionally bind to the NR12 receptor, and in the development of therapeutic drugs for diseases associated with immunity or hematopoiesis.

REFERENCES:
patent: 6642360 (2003-11-01), Filvaroff et al.
patent: 6747137 (2004-06-01), Weinstock et al.
patent: 6756481 (2004-06-01), Chirica et al.
patent: 7045595 (2006-05-01), Maeda et al.
patent: 7250168 (2007-07-01), Light et al.
patent: 7411041 (2008-08-01), Chirica et al.
patent: 7482440 (2009-01-01), Maeda et al.
patent: 2003/0082734 (2003-05-01), Dowling et al.
patent: 2003/0125520 (2003-07-01), Maeda et al.
patent: 2006/0106201 (2006-05-01), Maeda et al.
patent: 2006/0166284 (2006-07-01), Light et al.
patent: 2008/0019985 (2008-01-01), Light et al.
patent: 2008/0020965 (2008-01-01), Light et al.
patent: 2009/0023660 (2009-01-01), Maeda et al.
patent: 2009/0029484 (2009-01-01), Maeda et al.
patent: 2009/0105457 (2009-04-01), Maeda et al.
patent: 2009/0105458 (2009-04-01), Maeda et al.
patent: 2009/0105459 (2009-04-01), Maeda et al.
patent: 2009/0111972 (2009-04-01), Maeda et al.
patent: 2010/0016552 (2010-01-01), Maeda et al.
patent: 2010/0055092 (2010-03-01), Hasegawa et al.
patent: 0411946 (1991-02-01), None
patent: 0931646 (1999-07-01), None
patent: 1 088 831 (2001-04-01), None
patent: 1 188 830 (2002-03-01), None
patent: 2005-532045 (2005-10-01), None
patent: WO 95/33059 (1995-12-01), None
patent: WO 97/15663 (1997-01-01), None
patent: WO 97/07215 (1997-02-01), None
patent: WO 97/12037 (1997-03-01), None
patent: WO 99/67290 (1999-12-01), None
patent: WO 00/73451 (2000-12-01), None
patent: WO 00/75314 (2000-12-01), None
patent: WO 01/23556 (2001-04-01), None
patent: WO 01/23556 (2001-04-01), None
patent: WO 01/85790 (2001-11-01), None
patent: WO 02/00721 (2002-01-01), None
patent: WO 02/29060 (2002-04-01), None
patent: WO 02/077230 (2002-10-01), None
patent: WO 03/060090 (2003-07-01), None
patent: WO 03/072740 (2003-09-01), None
patent: WO 2004/003140 (2004-01-01), None
patent: WO 2006/063864 (2006-06-01), None
patent: WO 2006/081573 (2006-08-01), None
patent: WO 2006/088855 (2006-08-01), None
patent: WO 2006/088955 (2006-08-01), None
patent: WO 2006/088956 (2006-08-01), None
patent: WO 2006/122079 (2006-11-01), None
patent: WO2007133816 (2007-11-01), None
Meinkoth et al. Hybridization of nucleic acids immobilized on solid supports. Analytical Biochemistry vol. 138:267-284 (1984).
Abbas et al, Cellular and Molecular Immunology, Second edition, W.B. Saunders Company, Philadelphia, 1994.
Alexander, et al. “Suckling defect in mice lacking the soluble haemopoietin receptor NR6”, Current Biology, 9(11):605-608 (1999).
Bepler et al., A 1.4-Mb high-resolution physical map and contig of chromosome segment 11p15. 5 and genes in the LOH11A metastasis suppressor region, Genomics, 55(2):164-175 (1999).
Bork et al., “Go hunting in sequence databases but watch out for the traps,” Trends in Genetics 12:425-427 (1996).
Bork, “Powers and Pitfalls in Sequence Analysis: The 70% Hurdle,” Genome Research, 10:398-400 (2000).
Cosman, “The Hematopoietin Receptor Superfamily,” Cyokine, 5:95-106 (1993).
Gainsford et al., “Leptin can induce prolifieration, differentiation, and functional activation of hemopoietic cells,” Proc. Natl. Acad. Sci. USA, 93:14564-14568 (1996).
GenBank Accession No. AF102051 Dated 1999.
Hilton et al., “Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor,” Proc. Natl. Acad. Sci. USA, 93:497-501 (1996).
Myajima et al., “Cytokine receptors and signal transduction,” Annu. Rev. Immunol., 10:295-331 (1992).
Oppmann et al., “Novel p19 Protein Engages IL-12p40 to Form a Cytokine, IL-23, with biological Activities Similar as Well as Distinct from IL-12,” Immunity, 13:715-725 (2000).
Robb et al., “Structural Analysis of the Gene Encoding the Murine Interleukin-11 Receptor α-Chain and a Related Locus,” The Journal of Biological Chemistry, 271(23):13754-13761 (1996).
Saito et al., “Molecular Cloning of a Murine IL-6 Receptor-Associated Signal Transducer, gp130, and its Regulated Expression in Vivo,” The Journal of Immunology, 148(12):4066-4071 (1992).
Wells et al., “Hematopoietic Receptor Complexes,” Annu. Rev. Biochem., 65:609-634 (1996).
Wells, “Additivity of Mutational Effects in Proteins,” Biochem., 29:8509-8517 (1990).
Cosman et al., “A new cytokine receptor superfamily,”Trends Biochem. Sci., 15:265-270 (1990).
Miyazaki et al., “The integrity of the conserved ‘WS motif’ common to IL-2 and other cytokine receptors is essential for ligand binding and signal transduction,”EMBO J., 10(11):3191-3197 (1991).
Bepler et al., “A 1.4-Mb high-resolution physical map and contig of chromosome segment 11p15.5 and genes in LOH11A metastasis suppressor region”, Genomics 55(2):164-175, 1999.
Cioffi et al., “Novel B219/OB receptor isoforms: Possible role of leptin in hematopoiesis and reproduction”, Nature Medicine 2(5):585-589, 1996.
Dillon et al., “Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice”, Nature Immunology 5(7):752-760, 2004.
Diveu et al., “GPL, a novel cytokine receptor related to gp130 and leukemia inhibitory factor receptor”, J. Biol. Chem. 278(50):49850-49859, 2003.
Donaldson et al., “The murine IL-13 receptor α2: Molecular cloning, characterization, and comparison with murine IL-13 receptor α2”, The Journal of Immunology 161:2317-2324, 1998.
EMBL Accession No. AI123586, dated Sep. 8, 1998.
EMBL Accession No. W16834, dated May 4, 1996.
Genbank Accession No. AAM44229 (hIL-23R), Oct. 19, 2004.
Genbank Accession No. AY499342, Jul. 10, 2004.
Genbank Accession No. AQ022781, Jun. 16, 1998.
Genbank Accession No. NM—139017, Aug. 3, 2005.
Ghilardi et al., “A novel type I cytokine receptor is expressed on monocytes, signals proliferation, and activates STAT-3 and STAT-5”, J. Biol. Chem. 27(19):16831-16836, 2002.
Hibi et al., “Molecular cloning and expression of an IL-6 signal transducer, gp130”, Cell 63:1149-1157, 1990.
Hilton et al., “Cloning of a murine IL-11 receptor α-chain; requirement for gp 130 for high affinity binding and signal transduction”, The EMBO Journal 13(20):4765-4775, 1994.
Jabbour et al., “Expression of functional prolactin receptors in non-pregnant human endometrium: janus kinase-2, single transducer . . . ”, J. Clin. Endoconol. Metab. 83(7):2545-2553, 1998.
Kernebeck et al., “The signal transducer gp 130: solution structure of the carboxy-terminal domain of the cytokine receptor homology region”, Protein Science 8(1):5-12, 1999.
Mahairas et al., “Sequence-tagged connectors: A sequence approach to mapping and scanning the human genome”, Proc. Natl. Acad. Sci. USA 96(17):9730-9744 (1999).
Matsuno et al., “Treatment of rheumatoid synovitis with anti-reshaping human interleukin-6 receptor monoclonal antibody”, Arthritis & Rheumatism 41(11):2014-2021 (1998).
Matthews et al., “A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations”, Cell 65:1143-1152, 1991.
Murakami et al., “Critical cytoplasmic region of the interleukin 6 signal transducer gp130 is conserved in the cytokine receptor family&

Affiliated with

Also associated with

Rating

Hemopoietin receptor protein, NR12 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hemopoietin receptor protein, NR12, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hemopoietin receptor protein, NR12 will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2638083